L-DOPA (sodium)

CAT: 0804-HY-N0304A-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-N0304A-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
L-DOPA (Levodopa) sodium is an orally active metabolic precursor of neurotransmitters dopamine. L-DOPA sodium can cross the blood-brain barrier and is converted into dopamine in the brain. L-DOPA sodium has anti-allodynic effects, and can be used for Parkinson's disease research[1][2][3].
CAS Number
[63302-01-2]
Product Name Alternative
Levodopa (sodium) ; 3,4-Dihydroxyphenylalanine (sodium)
UNSPSC
12352005
Target
Dopamine Receptor; Endogenous Metabolite
Type
Reference compound
Related Pathways
GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/l-dopa-sodium.html
Purity
99.95
Solubility
10 mM in DMSO
Smiles
O=C([C@H](CC1=CC=C(C(O)=C1)O)N)O[Na]
Molecular Formula
C9H10NNaO4
Molecular Weight
219.17
References & Citations
[1]Hyland K, et al. Aromatic L-amino acid decarboxylase deficiency: diagnostic methodology. Clin Chem. 1992 Dec;38 (12) :2405-10.|[2]Merims D, et al. Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease. Parkinsonism Relat Disord. 2008;14 (4) :273-80. Epub 2007 Nov 7.|[3]Perez-Pardo P, et al. Additive Effects of Levodopa and a Neurorestorative Diet in a Mouse Model of Parkinson's Disease. Front Aging Neurosci. 2018 Aug 3;10:237.|[4]Park HJ, et al. Anti-allodynic effects of levodopa in neuropathic rats. Yonsei Med J. 2013 Mar 1;54 (2) :330-5.|[5]M Lundblad, et al. Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia. Exp Neurol. 2005 Jul;194 (1) :66-75. |[6]Jie Zhang, et al. Pharmacokinetics of L-dopa in plasma and extracellular fluid of striatum in common marmosets. Brain Res. 2003 Dec 12;993 (1-2) :54-8.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
Human Endogenous Metabolite

Related Products

CatalogName
HY-N0304-01L-DOPA
HY-113404S1L-Dopa-d3
HY-N0304S2-01L-DOPA-13C
HY-N0304S1-01L-DOPA-13C6
HY-N0304SL-DOPA-d6
HY-N0304R-01L-DOPA (Standard)
HY-121939-016-Hydroxy-L-DOPA
HY-176895L-Dopa precursor-1
HY-121939R6-Hydroxy-L-DOPA (Standard)
HY-141647[18F]-Labeled L-dopa precursor

Alternative Products

CatalogName
GC1128-1kgSodium L-ascorbate
JH667293Sodium L-pyroglutamate
TRC-S673600-50MGSodium L-Rhamnonate
sc-220120BSodium L-lactate
sc-215877(+) -Sodium L-ascorbate
BUP18449-01L-Thyroxine sodium
MBS5750384(L)-Sodium lactate
BUP15755-01(L) -Sodium lactate
L3080-01L- (+) Sodium glutamate
MF-0099323L-?-lysophosphatidylinositol sodium

Popular Products